GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioteque 4107.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

106.00

+1.92%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 2.14bn

FY2016FY2025

Net income

TWD 539.2m

FY2016FY2025

Free cash flow

TWD 606.7m

FY2016FY2025

Shareholders' equity

TWD 3.61bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 2.14bnTWD 2.07bnTWD 1.94bnTWD 2.01bnTWD 1.83bnTWD 1.95bnTWD 1.86bnTWD 1.61bnTWD 1.42bnTWD 1.41bn
Gross profitTWD 936.9mTWD 905.1mTWD 805.3mTWD 844.5mTWD 802.9mTWD 851.8mTWD 817.0mTWD 689.0mTWD 603.7mTWD 626.0m
Research and developmentTWD 73.3mTWD 76.3mTWD 70.4mTWD 70.0mTWD 68.8mTWD 71.8mTWD 51.5mTWD 38.0mTWD 37.8mTWD 55.7m
Operating incomeTWD 670.3mTWD 643.2mTWD 580.2mTWD 627.5mTWD 540.1mTWD 603.2mTWD 594.5mTWD 492.1mTWD 428.2mTWD 442.1m
Net incomeTWD 539.2mTWD 528.3mTWD 452.6mTWD 493.5mTWD 431.3mTWD 488.7mTWD 464.2mTWD 405.0mTWD 303.9mTWD 358.2m
Diluted earnings per share7.787.616.497.076.227.046.695.834.385.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 4.66bnTWD 4.65bnTWD 4.62bnTWD 4.48bnTWD 3.86bnTWD 3.56bnTWD 2.94bnTWD 2.77bnTWD 2.62bnTWD 2.56bn
Cash and short-term investments——TWD 1.57bnTWD 1.27bnTWD 1.31bnTWD 1.49bnTWD 1.23bnTWD 1.10bnTWD 1.09bnTWD 1.01bn
Total liabilitiesTWD 1.05bnTWD 1.20bnTWD 1.43bnTWD 1.45bnTWD 1.06bnTWD 899.5mTWD 452.4mTWD 457.5mTWD 484.7mTWD 486.4m
DebtTWD 153.3mTWD 740.6mTWD 894.5mTWD 872.4mTWD 471.6mTWD 336.1mTWD 25.5mTWD 71.1mTWD 161.9mTWD 136.4m
Shareholders' equityTWD 3.61bnTWD 3.44bnTWD 3.19bnTWD 3.03bnTWD 2.80bnTWD 2.66bnTWD 2.49bnTWD 2.31bnTWD 2.14bnTWD 2.08bn
Shares outstanding69m69m70m70m69m69m69m69m69m69m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 664.2mTWD 702.6mTWD 669.4mTWD 644.6mTWD 469.2mTWD 634.5mTWD 623.4mTWD 460.4mTWD 336.5mTWD 380.6m
Capital spending−TWD 57.5m−TWD 98.4m−TWD 97.6m−TWD 726.8m−TWD 550.9m−TWD 171.8m−TWD 139.4m−TWD 107.7m−TWD 63.4m−TWD 136.9m
Free cash flowTWD 606.7mTWD 604.2mTWD 571.8m−TWD 82.2m−TWD 81.6mTWD 462.7mTWD 484.0mTWD 352.7mTWD 273.1mTWD 243.8m
Dividends paid−TWD 346.5m−TWD 311.8m−TWD 311.8m−TWD 311.8m−TWD 277.2m−TWD 277.2m−TWD 277.2m−TWD 242.5m−TWD 207.9m−TWD 180.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 588.2mTWD 546.4mTWD 567.2mTWD 519.3mTWD 530.5mTWD 518.6mTWD 504.2mTWD 553.3m
Gross profitTWD 267.5mTWD 247.0mTWD 253.2mTWD 235.1mTWD 223.9mTWD 224.7mTWD 231.1mTWD 251.0m
Operating incomeTWD 196.1mTWD 176.0mTWD 180.3mTWD 168.4mTWD 162.4mTWD 159.1mTWD 163.0mTWD 188.1m
Net incomeTWD 152.3mTWD 145.0mTWD 155.6mTWD 136.6mTWD 112.5mTWD 134.5mTWD 134.2mTWD 143.8m
Diluted earnings per share2.202.092.241.971.621.941.932.07
Cash from operationsTWD 127.0mTWD 252.0mTWD 205.0mTWD 118.0mTWD 126.0mTWD 213.0mTWD 233.0mTWD 130.0m
Capital spending−TWD 20.0m−TWD 52.0m−TWD 12.0m−TWD 22.0m−TWD 7.0m−TWD 14.0m−TWD 23.0m−TWD 19.0m
Free cash flowTWD 107.0mTWD 200.0mTWD 193.0mTWD 96.0mTWD 119.0mTWD 199.0mTWD 210.0mTWD 111.0m
Total assetsTWD 4.88bnTWD 4.81bnTWD 4.66bnTWD 4.49bnTWD 4.75bnTWD 4.77bnTWD 4.65bnTWD 4.49bn
DebtTWD 75.8mTWD 104.7mTWD 153.3mTWD 186.9mTWD 220.4mTWD 254.0mTWD 296.4mTWD 333.9m
Shareholders' equityTWD 3.53bnTWD 3.38bnTWD 3.61bnTWD 3.44bnTWD 3.29bnTWD 3.24bnTWD 3.44bnTWD 3.29bn

Financial ratios

Data as of 8 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin43.9%43.7%41.4%42.0%44.0%43.7%—
Operating margin31.9%33.2%29.8%31.2%29.6%31.0%—
Net margin25.2%25.5%23.3%24.6%23.6%25.1%—
Return on equity14.9%15.4%14.2%16.3%15.4%18.3%—
Return on assets11.6%11.4%9.8%11.0%11.2%13.7%—
Free cash flow yield—10.5%10.0%17.9%13.4%10.6%10.0%
Revenue growth3.0%6.6%-3.3%10.1%-6.3%4.8%—
Earnings growth2.1%16.7%-8.3%14.4%-11.7%5.3%—
Current ratio4.27x3.92x3.35x3.34x3.27x4.89x—
Debt to equity0.04x0.09x0.19x0.19x0.06x0.03x—
Equity ratio77.4%74.1%69.0%67.7%72.6%74.8%—
Interest coverage90.46x73.39x50.00x145.29x284.71x481.03x—
R&D as a share of sales3.4%3.7%3.6%3.5%3.8%3.7%—
Buybacks as a share of market value—0.5%0.1%-0.7%0.1%-0.1%0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.0%1.9%5.4%
Operating income2.2%2.1%6.2%
Net income3.0%2.0%5.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin43.8%42.8%43.1%43.3%
Operating margin31.2%30.9%30.7%30.7%
Net margin25.4%24.7%24.6%24.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings15.516.216.915.818.418.919.516.222.622.9
Price to sales3.94.14.03.94.34.74.94.14.85.8

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 28 Jul 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year5.505.004.504.504.50
  • 103-for-100 split · 24 Aug 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.